Key result
Atrial natriuretic peptide decreased mean arterial pressure, an effect that was reverted by L-NAME, indicating that ANP modifies blood pressure through the nitric oxide pathway.
Why the study?
Does atrial natriuretic peptide modify arterial blood pressure through the nitric oxide pathway in rats?
Does atrial natriuretic peptide modify arterial blood pressure through the nitric oxide pathway in rats?
Answers are grounded in this paper and cite their sources.
The nitric oxide pathway acts as an intercellular messenger in the endothelium-dependent vasorelaxation mechanism of atrial natriuretic peptide.
The aim of the present study was to determine the relationship between the hypotensive effect of the atrial natriuretic peptide (ANP) and the nitric oxide (NO) pathway. N(G)-nitro-L-arginine methyl ester bolus (L-NAME, 1 mg/kg) reverted the decrease in mean arterial pressure induced by ANP administration (5 microg/kg bolus and 0.2 microg x kg(-1) x min(-1) infusion), and the injection of L-NAME before peptide administration suppressed the ANP hypotensive response. To confirm these findings, a histochemical reaction was used to determine NADPH-diaphorase activity (a NO synthase marker) in the endothelium and smooth muscle of aorta and arterioles of the small and large intestine. ANP increased aorta and arteriole endothelium staining after both in vivo administration and in vitro tissue incubation. In both cases, L-NAME prevented the ANP effect on NADPH-diaphorase activity. Tissues incubated with 8-bromoguanosine 3',5'-cyclic monophosphate mimicked ANP action. In addition, ANP administration increased urinary excretion of NO(x) end products. These findings indicate that ANP increases NO synthesis capability and NO production and suggest that the cGMP pathway may be involved. In conclusion, the NO pathway could be an intercellular messenger in the ANP endothelium-dependent vasorelaxation mechanism.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2000) studied this question. Atrial natriuretic peptide (ANP) vs. L-NAME was evaluated on mean arterial pressure. Atrial natriuretic peptide decreased mean arterial pressure, an effect that was reverted by L-NAME, indicating that ANP modifies blood pressure through the nitric oxide pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: